Is focal cortical dysplasia an infectious disease?

Epilepsy Currents

Volumn 13, Issue 5, 2013, Pages 226-228

  Wong, Michael ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; PROTEIN E6; PROTEIN S6; VIRUS DNA; VIRUS MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONTROLLED STUDY; CORTICAL DYSPLASIA; ELECTROPORATION; FETUS; FIBROBLAST; GENETIC TRANSFECTION; GLIOMA CELL; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFECTION; LYMPHOBLAST; MOUSE; NONHUMAN; NOTE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 84887544635     PISSN: 15357597     EISSN: 15357511     Source Type: Journal    
DOI: 10.5698/1535-7597-13.5.226     Document Type: Note

References (11)

1. Bast T, Ramantani G, Seitz A, Rating D. Focal cortical dysplasia: Prevalence, clinical presentation and epilepsy in children and adults. Acta Neurol Scand 2006;113:72-81.
2. Cohen-Gadol A, Ozduman K, Bronen RA, Kim JH, Spencer DD. Longterm outcome after epilepsy surgery for focal cortical dysplasia. J Neurosurg 2004;101:55-65.
3. Tassi L, Colombo N, Garbelli R, Francione S, Lo Russo G, Mai R, Cardinale F, Cossu M, Ferrario A, Galli C, Bramerio M, Citterio A, Spreafico R. Focal cortical dysplasia: Neuropathological subtypes, EEG, neuroimaging and surgical outcome. Brain 2002;125:1719-1732.
4. Blumcke I, Thom M, Aronica E, Armstrong DD, Vinters HV, Palmini A, Jacques TS, Avazini G, Barkovich AJ, Battaglia G, Becker A, Cepeda C, Cendes F, Colombo N, Crino P, Cross JH, Delalande O, Dubeau F, Duncan J, Guerrini R, Kahane P, Mathern G, Naim I, Ozkara C, Raybaud C, Represa A, Roper SN, Salamon N, Schulze-Bonhage A, Tassi L, Vezzani A, Spreafico R. The clinicopathologic spectrum of focal cortical dysplasias: A consensus classification proposed by an ad hoc task force of the ILAE Diagnostic Methods Commission. Epilepsia 2011;52:158-174.
5. Crino PB. mTOR: A pathogenic signaling pathway in developmental brain malformations. Trends Mol Med 2011;17:734-742.
6. Wong M, Crino PB. mTOR and epileptogenesis in developmental brain malformations. In: Jasper's Basic Mechanisms of the Epilepsies, 4th ed. (Noebels JL, Avoli M, Rogawski MA, Olsen RW, Delgado-Escueta AV, eds.) Bethesda, MD: National Center for Biotechnology Information, 2012:835-844.
7. Becker AJ, Urbach H, Scheffler BJ, Baden T, Normann S, Lahl R, Pennek HW, Tuxhorn I, Elger CE, Schramm J, Wiestler OD, Blumcke I. Focal cortical dysplasia of Taylor's balloon cell type: Mutational analysis of the TSC1 gene indicates a pathogenic relationship to Tuberous Sclerosis. Ann Neurol 2002;52:29-37.
8. Lu Z, Hu X, Li Y, Zheng L, Zhou Y, Jiang H, Ning T, Basang Z, Zhang C, Ke Y. Human papillomavirus 16 E6 oncoprotein intereferences with insulin signaling pathway by binding to tuberin. J Biol Chem 2004;279:35664-35670.
9. Spangle JM, Munger K. The human papillomavirus type 16 E6 oncoprotein activates mTORC1 signaling and increases protein synthesis. J Virol 2010;84:9398-9407.
10. Zhou Y, Pan Y, Zhang S, Shi X, Ning T, Ke Y. Increased phosphorylation of p70 S6 kinase is associated with HPV16 infection in cervical cancer and esophageal cancer. Br J Cancer 2007;97:218-222.
11. Bosnjak VM, Dakovic I, Duranoic V, Lujic L, Krakar G, Marn B. Malformations of cortical development in children with congenital cytomegalovirus infection-A study of nine children with proven congenital cytomegalovirus infection. Coll Antropol 2011;35(suppl):229-234.